Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden.
Cuesta MJ, Ballesteros A, Sánchez-Torres AM, Amoretti S, López-Ilundain JM, Merchán-Naranjo J, González-Ortega I, Salgado P, Rodriguez-Jimenez R, Roldán-Bejarano A, Sarró S, Ibáñez Á, Usall J, Escartí MJ, Moreno-Izco L, Mezquida G, Parellada M, González-Pinto A, Berrocoso E, Bernardo M; 2EPs group.
Cuesta MJ, et al. Among authors: salgado p.
Schizophr Res. 2022 Oct;248:331-340. doi: 10.1016/j.schres.2022.09.014. Epub 2022 Sep 22.
Schizophr Res. 2022.
PMID: 36155307